A REVIEW ON CHITOSAN NANOPARTICLES FOR THE TREATMENT OF TUBERCULOSIS
*Jisha Johnson, Junise V., Naseena U., Rekha M.
ABSTRACT
Tuberculosis is a significant public health issue. The current article examines the most recent developments in the use of nanoparticles to treat tuberculosis. Polymers in various forms, such as liposomes, dendrimers, and Nanoemulsions, may be utilized as synthetic and natural carriers for the treatment's first and second-line medicines. This aids in the reduction of their doses, the reduction of side effects, the rise in medication interactions, and the targeting of drug-resistant bacteria. Because of the difficulties in developing anti-tuberculosis drugs, Nanotherapeutics utilizing chitosan as a carrier, emerged as a silver lining. Because chitosan is a more convenient and cost-effective way to distribute drugs.
Keywords: Tuberculosis, Mycobacterium tuberculosis, Chitosan
[Full Text Article]
[Download Certificate]